Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

449 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials.
Sterner Isaksson S, Imberg H, Hirsch IB, Schwarcz E, Hellman J, Wijkman M, Bolinder J, Nyström T, Holmer H, Hallström S, Ólafsdóttir AF, Pekkari S, Polonsky W, Lind M. Sterner Isaksson S, et al. Among authors: hirsch ib. Diabetologia. 2024 Aug;67(8):1517-1526. doi: 10.1007/s00125-024-06151-2. Epub 2024 Apr 26. Diabetologia. 2024. PMID: 38668761 Free PMC article. Clinical Trial.
Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial).
Lind M, Hirsch IB, Tuomilehto J, Dahlqvist S, Torffvit O, Pehrsson NG. Lind M, et al. Among authors: hirsch ib. Prim Care Diabetes. 2015 Feb;9(1):15-22. doi: 10.1016/j.pcd.2014.07.010. Epub 2014 Aug 28. Prim Care Diabetes. 2015. PMID: 25175385 Clinical Trial.
A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes.
Matuleviciene V, Joseph JI, Andelin M, Hirsch IB, Attvall S, Pivodic A, Dahlqvist S, Klonoff D, Haraldsson B, Lind M. Matuleviciene V, et al. Among authors: hirsch ib. Diabetes Technol Ther. 2014 Nov;16(11):759-67. doi: 10.1089/dia.2014.0238. Epub 2014 Sep 18. Diabetes Technol Ther. 2014. PMID: 25233297 Free PMC article.
Assessing the Accuracy of Continuous Glucose Monitoring (CGM) Calibrated With Capillary Values Using Capillary or Venous Glucose Levels as a Reference.
Andelin M, Kropff J, Matuleviciene V, Joseph JI, Attvall S, Theodorsson E, Hirsch IB, Imberg H, Dahlqvist S, Klonoff D, Haraldsson B, DeVries JH, Lind M. Andelin M, et al. Among authors: hirsch ib. J Diabetes Sci Technol. 2016 Jun 28;10(4):876-84. doi: 10.1177/1932296815626724. Print 2016 Jul. J Diabetes Sci Technol. 2016. PMID: 26810924 Free PMC article. Clinical Trial.
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study).
Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Pehrsson NG, Moström P. Lind M, et al. Among authors: hirsch ib. J Diabetes Sci Technol. 2016 May 3;10(3):754-61. doi: 10.1177/1932296816642578. Print 2016 May. J Diabetes Sci Technol. 2016. PMID: 27081191 Free PMC article. Clinical Trial.
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Schwarz E, Ólafsdóttir AF, Frid A, Wedel H, Ahlén E, Nyström T, Hellman J. Lind M, et al. Among authors: hirsch ib. JAMA. 2017 Jan 24;317(4):379-387. doi: 10.1001/jama.2016.19976. JAMA. 2017. PMID: 28118454 Clinical Trial.
Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting.
Schnell O, Barnard K, Bergenstal R, Bosi E, Garg S, Guerci B, Haak T, Hirsch IB, Ji L, Joshi SR, Kamp M, Laffel L, Mathieu C, Polonsky WH, Snoek F, Home P. Schnell O, et al. Among authors: hirsch ib. Diabetes Technol Ther. 2017 Jul;19(7):391-399. doi: 10.1089/dia.2017.0054. Epub 2017 May 22. Diabetes Technol Ther. 2017. PMID: 28530490 Free PMC article. Review.
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3).
Dahlqvist S, Ahlén E, Filipsson K, Gustafsson T, Hirsch IB, Tuomilehto J, Imberg H, Ahrén B, Attvall S, Lind M. Dahlqvist S, et al. Among authors: hirsch ib. BMJ Open Diabetes Res Care. 2018 Feb 24;6(1):e000464. doi: 10.1136/bmjdrc-2017-000464. eCollection 2018. BMJ Open Diabetes Res Care. 2018. PMID: 29527308 Free PMC article.
449 results